Hypolipidemic agent. Exhibits higher potency than nicotinic acid and clofibrate. Full and potent agonist at the human orphan GPCR HM74A/GPR109A and GPR109B (EC50 values are 1.3 and 4.2 μM respectively). Reduces serum triglycerides and circulating LDL-cholesterol in vivo, without affecting liver weight or liver enzymes. Purity 99%. MW (observed): 218.21
Size
50 mg
Concentration
n/a
Applications
n/a
Other Names
4,5-Dihydro-5-methyl-4-oxo-5-phenyl-2-furancarboxylic acid. AY 25712